Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

China Proton Therapy Market Report 2017-2022 - Research and Markets

DUBLIN, May 9, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "China Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022" report to their offering.

Research and Markets Logo

China Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market.

Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem in the country. With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers.

Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients. There are currently two operational proton therapy centers in China. IBA has one operational proton therapy center in China while 4 more centers are in development phase.


Key Topics Covered:

1. Executive Summary

2. China Proton Therapy Market Analysis
2.1 China Proton Therapy - Actual and Potential Market (2014 - 2022)
2.2 China Proton Therapy Patients Number - Actual and Potential (2014 - 2022)

3. China - List of Proton Therapy Centers, Start of Treatment

4. China - Number of Patients Treated at Proton Therapy Centers
4.1 Wanjie Proton Therapy Center (WPTC) - Number of Patients Treated (2007 - 2013)
4.2 Shanghai Proton & Heavy Ion Center (SPHIC) - Number of Patients Treated (2014 - 2015)

5. Current Radiation Therapies
5.1 Third Dimensional Conformal Therapy (CRT)
5.2 Image Guided Radiotherapy (IGRT)
5.3 Intensity Modulated Radiotherapy (IMRT)
5.4 Stereotactic Radiotherapy
5.5 Neutron Therapy
5.6 Heavy Ion Radiotherapy
5.7 Proton Therapy

6. Components of a Standard Proton Therapy Center
6.1 Proton Accelerator
6.2 Beam Transport System
6.3 Beam Delivery System
6.4 Nozzle
6.5 Treatment Planning System
6.6 Image Viewers
6.7 Patient Positioning System (PPS)
6.8 Human Resource

7. Proton Therapy - Driving Factors
7.1 Technology Advancement
7.2 Growing Incidence of Cancer Patients
7.3 Proton Therapy Provides Enormous Benefits

8. Proton Therapy - Challenges
8.1 Requires Huge Investment
8.2 Operations Challenges
8.3 More Clinical Evidence Is Needed

For more information about this report visit http://www.researchandmarkets.com/research/p5z2hf/china_proton


Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.